Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 2 |
| Sosei Group Corporation, Medical Devices Deals, 2010 to YTD 2016 | 11 | 1 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 12 | 2 |
| Sosei Group Corporation, Pharmaceuticals &Healthcare, Deal Details | 14 | 40 |
| Venture Financing | 14 | 1 |
| Heptares Therapeutics Raises US$21 Million In Series B Financing | 14 | 2 |
| Partnerships | 16 | 1 |
| Heptares Therapeutics and leadXpro Enter into Agreement | 16 | 1 |
| Heptares Therapeutics to Form Partnership with Kymab | 17 | 1 |
| Heptares Therapeutics Enters into Agreement with Pfizer | 18 | 1 |
| Sosei Plans to Enter into Agreement with Novartis | 19 | 1 |
| Sosei Enters Into Distribution Agreement With Fujifilm Pharma For SO-1105 | 20 | 1 |
| MorphoSys And Heptares Enter Into Agreement To Develop Antibody Therapeutics Targeting GPCRs | 21 | 2 |
| Heptares Enters Into Research Agreement With Cubist Pharma For New Medicines Targeting GPCRs | 23 | 1 |
| ZoBio Enters Into Drug Discovery Agreement With Heptares Therapeutics For Fragment Ligands | 24 | 1 |
| Activus Pharma Enters Into Co-Development Agreement With CEOLIA Pharma | 25 | 1 |
| Activus Pharma Enters Into An Agreement With Gifu Pharma University | 26 | 1 |
| AstraZeneca Enters Into Co-Development Agreement With Heptares | 27 | 2 |
| Sosei Enters Into Co-Development Agreement With Toa Pharma | 29 | 1 |
| Heptares Therapeutics Enters Into Drug Discovery Collaboration With Takeda Pharma | 30 | 2 |
| Licensing Agreements | 32 | 1 |
| Allergan Enters into Licensing Agreement with Heptares Therapeutics | 32 | 2 |
| Teva Pharma Enters into Licensing Agreement with Heptares Therapeutics | 34 | 1 |
| AstraZeneca to Enter into Licensing Agreement with Heptares Therapeutics for HTL-1071 | 35 | 2 |
| Shire Exercises Option To License Adenosine A2A From Heptares Therapeutics | 37 | 2 |
| BioAlliance Pharma Extends Licensing Agreement With Sosei For Loramyc | 39 | 1 |
| Equity Offering | 40 | 1 |
| Sosei Group Raises USD33 Million in Private Placement of Shares | 40 | 2 |
| Sosei Group to Raise USD7 Million in Private Placement of Shares | 42 | 2 |
| Sosei Group to Raise USD66 Million in Public Offering of Shares | 44 | 2 |
| Jitsubo to Raise USD1.7 Million in Private Placement | 46 | 1 |
| Sosei Announces Private Placement Of Preference Shares For US$3.9 Million | 47 | 2 |
| Asset Transactions | 49 | 1 |
| Beijing Tide Pharma Acquires Rights To SD118 From Sosei | 49 | 1 |
| Acquisition | 50 | 1 |
| Sosei Acquires Heptares Therapeutics for USD400 Million | 50 | 2 |
| Sosei to Acquire Stake in Jitsubo for USDUSD1.8 Million | 52 | 1 |
| Sosei Group Acquires Activus Pharma | 53 | 1 |
| Sosei Group Corporation - Key Competitors | 54 | 1 |
| Key Employees | 55 | 1 |
| Locations And Subsidiaries | 56 | 2 |
| Head Office | 56 | 1 |
| Other Locations &Subsidiaries | 56 | 2 |
| Appendix | 58 | 1 |
| Methodology | 58 | 1 |
| About GlobalData | 58 | 1 |
| Contact Us | 58 | 1 |
| Disclaimer | 58 | 1 |